chemerin



chemerin

E1EE1L2LL2T3TT3E4EE4A5AA5Q6QQ6R7RR7R8RR8G9GG9L10LL10Q11QQ11V12VV12A13AA13L14LL14E15EE15E16EE16F17FF17H18HH18K19KK19H20HH20P21PP21P22PP22V23VV23Q24QQ24W25WW25A26AA26F27FF27Q28QQ28E29EE29T30TT30S31SS31V32VV32E33EE33S34SS34A35AA35V36VV36D37DD37T38TT38P39PP39F40FF40P41PP41A42AA42G43GG43I44II44F45FF45V46VV46R47RR47... and 87 more residue(s)...... and 87 more residue(s)

SMILES None
InChIKey None
Sequence ELTEAQRRGLQVALEEFHKHPPVQWAFQETSVESAVDTPFPAGIFVRLEFKLQQTSCRKRDWKKPECKVRPNGRKRKCLACIKLGSEDKVLGRLVHCPIETQVLREAEEHQETQCLRVQRAGEDPHSFYFPGQF

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



Bioactivities

chemerin

E1EE1L2LL2T3TT3E4EE4A5AA5Q6QQ6R7RR7R8RR8G9GG9L10LL10Q11QQ11V12VV12A13AA13L14LL14E15EE15E16EE16F17FF17H18HH18K19KK19H20HH20P21PP21P22PP22V23VV23Q24QQ24W25WW25A26AA26F27FF27Q28QQ28E29EE29T30TT30S31SS31V32VV32E33EE33S34SS34A35AA35V36VV36D37DD37T38TT38P39PP39F40FF40P41PP41A42AA42G43GG43I44II44F45FF45V46VV46R47RR47... and 87 more residue(s)...... and 87 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.